Additional file 1 of Assessing lung cancer progression and survival with infrared spectroscopy of blood serum
Additional file 1. Additional file 1: Tables S1-S5. Table S1 – details on laboratory parameters. Table S2 – numbers of patients with various comorbidities. Table S3 – cohort breakdown in terms of three classesused in the definition of patient stages, following the TNM Classification of Malignant Tumors. Table S4 – p-values for comparing survival functions related to different TNM tumor stages using log-rank testing. Table S5 – characteristics of the lung cancer cohort used in the analysis related to the results shown in Fig. 4a and b.
Institutions
- Max Planck Institute of Quantum Optics (DE)
- Asklepios Fachkliniken München-Gauting (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Figshare
- Published
- 2025-01-01
- DOI
- https://doi.org/10.6084/m9.figshare.28463298
- Primary Topic
- Legal and Regulatory Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00